Breaking News
Get 40% Off 0
📈 Free Gift Friday: Instantly Copy Legendary Investors' Portfolios Copy for Free
Close

GSK plc DRC (GSK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow GSK plc DRC's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
44.84 +0.17    +0.37%
09:46:47 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 323,362
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 44.81 - 44.98
GSK plc DRC 44.84 +0.17 +0.37%

GSK Recent Sentiments

 
This page contains information on users’ sentiments for the GSK plc DRC stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
May 10, 2024 Eddie Hartman   44.83 0.00%
May 07, 2024 Davide Dalmonte   44.02 +1.84%
Apr 10, 2024 Dih Lesnock   40.92 Apr 15, 2024 @ 40.90 -0.05%
Apr 03, 2024 John Amicaterra   41.51 Apr 26, 2024 @ 41.12 -0.94%
Mar 27, 2024 Tim Patterson   42.63 Apr 01, 2024 @ 42.26 -0.87%
Mar 14, 2024 www tw   43.44 Mar 18, 2024 @ 42.31 -2.60%
Mar 06, 2024 Davide Dalmonte   42.55 Mar 29, 2024 @ 42.86 +0.73%
Feb 20, 2024 Lukas Makurat   41.92 Feb 26, 2024 @ 42.34 +1.00%
Feb 05, 2024 Davide Dalmonte   41.88 Mar 01, 2024 @ 42.03 +0.36%
Feb 05, 2024 William Hineser   41.72 Mar 01, 2024 @ 42.03 +0.74%
Feb 05, 2024 mario korol   41.68 Feb 12, 2024 @ 40.95 -1.75%
Jan 12, 2024 Davide Dalmonte   40.06 Feb 02, 2024 @ 40.73 +1.67%
Jan 08, 2024 Oussama Riache   39.10 Jan 08, 2024 @ 39.42 +0.82%
Jan 05, 2024 Fidel Delgado   39.00 Jan 08, 2024 @ 39.42 +1.08%
Jan 04, 2024 Floky Floky   38.98 Jan 26, 2024 @ 39.07 +0.23%
Dec 26, 2023 Cepajes Representació   36.98 Jan 01, 2024 @ 37.05 +0.19%
Dec 19, 2023 mertz1966   36.48 Dec 25, 2023 @ 36.99 +1.40%
Dec 18, 2023 Андрей Фёдоров   36.47 Jan 12, 2024 @ 40.10 +9.95%
Dec 18, 2023 Kristof Brader   36.39 Jan 12, 2024 @ 40.10 -10.20%
Dec 18, 2023 Davide Dalmonte   35.88 Dec 18, 2023 @ 36.46 +1.62%
Dec 04, 2023 Marcos Gutierrez   36.59 Dec 29, 2023 @ 37.05 +1.26%
Nov 21, 2023 Augusto Martins   35.50 Dec 15, 2023 @ 35.88 -1.07%
Nov 14, 2023 Mechi Long   34.52 Nov 30, 2023 @ 35.49 +2.81%
Nov 08, 2023 William Hineser   35.24 Dec 01, 2023 @ 36.59 +3.83%
Nov 03, 2023 Giovanni Farinelli   34.41 Nov 30, 2023 @ 35.49 +3.14%
Oct 21, 2023 Christian Adams   35.00 Nov 30, 2023 @ 35.49 +1.40%
Oct 12, 2023 Murilo Cabral   37.15 Nov 30, 2023 @ 35.49 +4.47%
Sep 21, 2023 TJ POPOOLA   37.71 Nov 30, 2023 @ 35.49 -5.89%
Aug 03, 2023 Sérgio Veloso   34.00 Sep 25, 2023 @ 37.63 +10.68%
Jul 24, 2023 Elon Ge   35.85 Nov 30, 2023 @ 35.49 -1.00%
Jul 18, 2023 Joao Steinle   34.78 Nov 30, 2023 @ 35.49 +2.04%
Jun 28, 2023 Diego Millonario   35.56 Nov 30, 2023 @ 35.49 -0.20%
Jun 23, 2023 Davide Dalmonte   36.38 Nov 30, 2023 @ 35.49 -2.45%
Jun 06, 2023 constanza stragiotti   34.55 Nov 30, 2023 @ 35.49 +2.72%
May 18, 2023 Андрей Фёдоров   35.41 Nov 30, 2023 @ 35.49 +0.23%
May 05, 2023 Polter Geist   36.69 May 09, 2023 @ 36.77 +0.22%
Apr 27, 2023 Francisco Gomes da...   35.93 May 09, 2023 @ 36.45 +1.45%
Apr 27, 2023 Arth Dlg   36.00 May 09, 2023 @ 36.77 +2.14%
Apr 18, 2023 Garavari L   36.80 Nov 30, 2023 @ 35.49 -3.56%
Apr 14, 2023 Joao Steinle   37.70 Apr 17, 2023 @ 37.52 -0.48%
Apr 06, 2023 Davide Dalmonte   38.14 May 09, 2023 @ 36.77 -3.59%
Apr 04, 2023 vijay valtati   36.42 May 09, 2023 @ 36.77 +0.96%
Mar 29, 2023 alessandro acz   34.99 Apr 03, 2023 @ 35.73 +2.11%
Mar 23, 2023 Juan Ramon   35.49 Apr 14, 2023 @ 37.77 +6.42%
Mar 17, 2023 Igor Gee   34.06 Mar 20, 2023 @ 34.66 -1.76%
Mar 17, 2023 William Hineser   33.98 Apr 07, 2023 @ 38.00 +11.83%
Mar 10, 2023 Ruby Page   33.72 Mar 31, 2023 @ 35.58 +5.52%
Mar 08, 2023 esteban marquez   33.62 Mar 31, 2023 @ 35.58 -5.83%
Mar 08, 2023 Андрей Фёдоров   33.91 Mar 31, 2023 @ 35.58 +4.92%
Feb 28, 2023 Lucas Soler   34.54 Mar 24, 2023 @ 34.38 -0.46%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GSK Comments

Write your thoughts about GSK plc DRC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
William Hineser
William Hineser Feb 28, 2024 2:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Most large international pharm companies are good long term investments.
William Hineser
William Hineser Feb 05, 2024 9:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Finally, some improvement, with reservations.
William Hineser
William Hineser Nov 14, 2023 10:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
One of the few pharm companies not improving. Why?
Arth Dlg
Arth Dlg Apr 27, 2023 9:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
RSV approval is a great announcement. I am buying :)
Jeff Chui
Jeff Chui Sep 15, 2022 9:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy here 31.2 Someone just bought 700k shares ($21million) pre market
daniel daniel
daniel daniel Sep 15, 2022 9:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yes i entered at the same price, went against my rule of waiting the SPY to fall to the support level which would be around 365, i hope it was not a trick to get some new hodlers .... yet i feel relaxed because of the high dividend
peter pan
peter pan Aug 18, 2022 7:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GSK will fall to $25 level. Mark my words.
Jay Ow
Jay Ow Aug 18, 2022 7:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They all can do whatever after covid fraud. I do not want see any of these MED stocks at all for me and for many others they are just Murderers
Dan Dc
DanDc Aug 17, 2022 10:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bought @ 34.36
Jaeyong Lee
Jaeyong Lee Aug 17, 2022 10:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bought @33.07
Dan Dc
DanDc Aug 17, 2022 10:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i bought for long term , now the stimulus in Europe will pump this stock.
Patricio Garnica
Patricio Garnica Aug 11, 2022 1:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is It a good entry point?
Mo Ali
Av8er31 Aug 11, 2022 1:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Absolutely.
William Hineser
William Hineser Aug 11, 2022 10:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Glad I don't have many shares.
True Thao
True Thao Aug 11, 2022 10:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
🤣🤣🤣
Jonathan Sanders
Jonathan Sanders Aug 03, 2022 9:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GSK recently struck a deal to purchase Sierra Oncology (SRRA) for a total of $1.9 billion to bolster its oncology offerings.... what we think about this acquisition
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email